Hudson Bay Capital Management LP Ultragenyx Pharmaceutical Inc. Transaction History
Hudson Bay Capital Management LP
- $21.9 Billion
- Q3 2024
A detailed history of Hudson Bay Capital Management LP transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 195,000 shares of RARE stock, worth $8.2 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
195,000
Previous 415,000
53.01%
Holding current value
$8.2 Million
Previous $17.1 Million
36.49%
% of portfolio
0.05%
Previous 0.09%
Shares
22 transactions
Others Institutions Holding RARE
# of Institutions
324Shares Held
85.6MCall Options Held
520KPut Options Held
406K-
Vanguard Group Inc Valley Forge, PA9.95MShares$418 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$236 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA5.12MShares$215 Million0.91% of portfolio
-
Wellington Management Group LLP Boston, MA4.17MShares$175 Million0.04% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.07MShares$129 Million0.02% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.95B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...